论文部分内容阅读
目的探究甲泼尼龙药物辅助治疗小儿大叶性支原体肺炎的效果。方法 68例大叶性支原体肺炎患儿,按照患儿的入院顺序分为干预组和参照组,每组34例。参照组患儿行常规的药物治疗,干预组患儿在参照组的基础上行甲泼尼龙药物辅助治疗。对比两组患儿的症状缓解时间、住院时间以及治疗效果。结果经治疗,干预组患儿的症状缓解时间和住院时间均短于参照组,差异具有统计学意义(P<0.05);干预组患儿的治疗效果明显优于参照组,差异具有统计学意义(P<0.05)。结论利用甲泼尼龙药物辅助治疗肺炎的效果显著,能缓解疾病症状、缩短治疗时间并提高疾病的治愈率,值得在临床推广。
Objective To investigate the effect of methylprednisolone in adjuvant treatment of Mycoplasma pneumonia in children. Methods Sixty-eight children with mycoplasma pneumonia were divided into two groups: intervention group and control group, with 34 cases in each group. The reference group of children with conventional drug treatment, intervention group children in the reference group on the basis of methylprednisolone drug-assisted therapy. The symptom relief time, hospitalization time and treatment effect of two groups were compared. Results After treatment, the symptom relief time and hospitalization time in the intervention group were shorter than the reference group, the difference was statistically significant (P <0.05); the therapeutic effect of intervention group was significantly better than the reference group, the difference was statistically significant (P <0.05). Conclusions The use of methylprednisolone to treat pneumonia is effective in relieving the symptoms of the disease, shortening the treatment time and improving the cure rate of the disease, which is worthy of clinical promotion.